Ex vivo studies after oral treatment of the beagle with dihydroergotamine
- 22 April 1983
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 89 (1-2) , 1-8
- https://doi.org/10.1016/0014-2999(83)90601-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Bioavailability of dihydroergotamine in man.British Journal of Clinical Pharmacology, 1982
- Low oral bioavailability of dihydroergotamine and first-pass extraction in patients with Orthostatic hypotensionClinical Pharmacology & Therapeutics, 1981
- Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension.BMJ, 1980
- Unchanged venoconstrictor activity of locally synthesized prostaglandins in graftsEuropean Journal of Pharmacology, 1979
- Treatment of orthostatic hypotension with dihydroergotamine.BMJ, 1979
- Dihydroergotamine binding to rat brain membranesLife Sciences, 1976
- ERGOTAMINE AND METHYSERGIDE AS SEROTONIN PARTIAL AGONISTS IN MIGRAINEHeadache: The Journal of Head and Face Pain, 1976
- Modification of canine vascular smooth muscle responses to dihydroergotamine by endogenous prostaglandin synthesisEuropean Journal of Pharmacology, 1975
- Studies on the peripheral mode of action of dihydroergotamine in human and canine veinsEuropean Journal of Pharmacology, 1974
- Comparative Effects of Dihydroergotamine and Noradrenaline on Resistance, Exchange and Capacitance Functions in the Peripheral CirculationClinical Science, 1970